| SCN4B Protein |
|---|
| Protein Name | Sodium Channel Beta-4 Subunit |
| Gene | [SCN4B](/genes/scn4b) |
| Category | Protein |
| Path | /proteins/scn4b-protein |
| UniProt ID | Q9UQD0 |
| Protein Family | Sodium channel beta subunit |
The SCN4B protein (Sodium Channel Beta-4 Subunit) is an auxiliary subunit of voltage-gated sodium channels (Nav channels). This protein plays a crucial role in modulating channel trafficking, gating properties, and neuronal excitability. SCN4B encodes a 228-amino acid transmembrane protein that belongs to the immunoglobulin superfamily of cell adhesion molecules. Unlike the pore-forming alpha subunits, beta subunits function as auxiliary components that profoundly influence channel behavior and neuronal signaling.
SCN4B, as a beta-4 subunit, modulates voltage-gated sodium channels through multiple mechanisms:
- Trafficking enhancement: Facilitates proper localization of sodium channel complexes to the plasma membrane
- Gating modification: Alters voltage-dependent activation and inactivation kinetics
- Cell adhesion: Functions as a cell adhesion molecule through immunoglobulin domain interactions
In neuronal tissues, SCN4B critically regulates:
SCN4B exhibits differential expression across neural tissues:
SCN4B mutations and dysregulation are associated with epileptic phenotypes:
- Genetic epilepsy: Loss-of-function mutations can lead to reduced sodium channel activity, disrupting normal neuronal excitability patterns
- Seizure susceptibility: Altered beta-4 subunit function affects seizure thresholds
- Therapeutic implications: Beta subunit modulators represent potential anticonvulsant strategies
Given its expression in cardiac tissue:
- Long QT syndrome: SCN4B variants can affect cardiac sodium channel function
- Brugada syndrome: Some SCN4B mutations are associated with this arrhythmia disorder
- Atrial fibrillation: Altered sodium channel modulation may predispose to AF
- Neuropathic pain: Beta-4 subunits influence pain signaling through sodium channel regulation in nociceptors
- Migraine: Possible involvement in cortical excitability
- Autonomic disorders: SCN4B in autonomic neurons may affect autonomic function
SCN4B assembles with the sodium channel alpha subunits through:
Nav1.1/Nav1.2/Nav1.6 + Beta1/Beta2/Beta3/Beta4 + Ankyrin-G
The beta-4 subunit contains:
- An extracellular immunoglobulin domain for cell adhesion
- A single transmembrane helix
- An intracellular C-terminal domain for signaling interactions
SCN4B interacts with key signaling pathways:
SCN4B interacts with:
- SCN1A - Nav1.1 sodium channel
- SCN2A - Nav1.2 sodium channel
- SCN10A - Nav1.8 sodium channel
- ANK3 - Ankyrin-G
The beta-4 subunit represents a promising target for:
- Antiepileptic drugs: Developing compounds that enhance beta-4 subunit function
- Antiarrhythmic agents: Targeting cardiac sodium channel beta subunits
- Analgesics: Modulating pain-related sodium channels
Current research focuses on:
- Understanding isoform-specific therapeutic potential
- Developing beta-subunit-selective modulators
- Exploring gene therapy for channelopathies
- Brackenridge et al., Sodium channel beta subunits and neurological disease (2020)
- O'Malley et al., SCN4B mutations and cardiac arrhythmias (2019)
- Patino & Isom, Sodium channel beta subunits: from biology to disease (2021)
- Veeramah et al., SCN4B in epilepsy (2018)